MARKET RADAR
SENSEX     NIFTY      
Sun Pharmaceutical Industries Homepage >> Stock Price >> Sun Pharma >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages

Sun Pharmaceutical Industries

  BSE: 524715  |  NSE: SUNPHARMA  |  ISIN: INE044A01036
    
Add to Portfolio : Buy Date Qty Price |
541.30 -0.65 (-0.12%)
BSE : Feb 10, 17:00
Open 552.70 Vol 35,752
High 552.75 52 Wk 565.75
Low 538.10 52 Wk 404.00
Prev. Close 541.95    
541.45 -1.30 (-0.24%)
NSE : Feb 10, 17:00
Open 544.00 Vol 955,167
High 545.15 52 Wk 603.00
Low 538.00 52 Wk 403.55
Prev. Close 542.75    
- Related links
Track Sun Pharmaceutical Industries 24x7
Get price sensitive and timely news updates on your mobile for just Re 1 a day
Activate Now
  Bid Offer
Price 541.30 0.00
Quantity 1.00 0.00
  Bid Offer
Price 541.45 0.00
Quantity 266.00 0.00
Market Cap 56,056.05 | * EPS (TTM) 15.22 | * P/E 35.57 | * P/C 34.17
* Book Value 64.51 | * Price/Book 8.39 | Div(%) 350.00 | Div Yield(%) 0.65
Market Lot 1.00 | Face Value 1.00 | Industry P/E 11.00
* As per latest stand alone adjusted profit after extra-ordinary items.

F&O Quote of Sun Pharma

Historic Prices of Sun Pharma

on 1 week 1 month 3 month 1 year 2 year 3 year
1 YearCurrent% Gain/Loss
Open Price 407.90552.70
High Price 424.80552.75
Low Price 407.30538.10
Last Price 417.10541.3029.78
Volume23944035752-85.07

Financials of Sun Pharma

Income Statement (Sep '11) (Mar '11)
  Quarterly Annual
Net Sales 938.65 1933.12
Other Income 13.42 71.08
PBDIT 429.96 397.52
Net Profit 437.55 1383.80
Profit & Loss | Half Yearly Results | Quarterly Results
Balance Sheet
Total Share Capital 103.56
Net Worth 6680.53
Total Debt 50.53
Net Block 794.39
Investments 3601.42
Net Current Assets 2107.19
Total Assets 6731.06
Balance Sheet | Finished Goods | Raw Materials

Mutual Funds Holding - Sun Pharma

Compare with Peers

What's your call on Sun Pharma

Experience the thrills of
investing with no risk

Community on Sun Pharma

News Events - Sun Pharma

BSE / NSE Notices - Sun Pharma

Expert Advice - Sun Pharma

No Expert Advice in the last 7 days

Queries on Sun Pharma

Question asked by pro77

at 10:17 PM

whats the next target?

Question asked by prabhak

at 12:11 PM

why its going down? Any negati...

Post a query

See all queries

Groups: Pharmaceuticals

Company Last Price Market Cap
Cipla 349.00 28,021.96
Dr Reddys Labs 1,619.85 27,452.54
Lupin 458.80 20,487.26
Ranbaxy Labs 443.30 18,679.03
GlaxoSmithKline 2,032.95 17,219.70
more...

Compare with peers

Simple Moving Averages - Sun Pharma

Days BSE NSE
30 523.23 523.65
50 517.19 517.66
150 500.10 500.34
200 491.09 491.31

Company Facts - Sun Pharma

Registered Address

Sun Pharma Advanced Research Centre (SP
Tandalja,,Akota Road
Vadodra
Gujarat
390020

Tel: 0265-337539
Fax: 0265-332664
Email: secretarial@sunpharma.com
Website: http://www.sunpharma.com

Registrars

Link Intime India Pvt. Ltd. C-13, Pannalal Silk Mill Compound,
LBS Marg,
Bhandup (West)

Mumbai - 400078
Maharashtra

Tel: 022-25960320
Fax: 022-25960329
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Sun Pharma

Name Designation
Dilip S Shanghvi Chairman and Managing director
S Kalyanasundaram Wholetime Director & CEO
S Mohanchand Dadha Director
Keki M Mistry Director
Name Designation
Sudhir V Valia Whole Time Director
Sailesh T Desai Whole Time Director
Hasmukh S Shah Director
Ashwin Dani Director
Type
S Sun Pharma
SMS to 51818 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Block Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
India gold demand returns as prices ease. Will gold prices correct further?
Yes
No
 

Follow moneycontrol.com